399 related articles for article (PubMed ID: 27068103)
1. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
2. Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells.
Mori K; Fujimoto-Ouchi K; Onuma E; Noguchi M; Shimonaka Y; Yasuno H; Nishimura T
Biomed Res; 2009 Feb; 30(1):47-51. PubMed ID: 19265263
[TBL] [Abstract][Full Text] [Related]
3. Effects of IL-10 on iron metabolism in LPS-induced inflammatory mice via modulating hepcidin expression.
Huang P; Wang J; Lin X; Yang FF; Tan JH
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3469-3475. PubMed ID: 28829493
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.
Song SN; Tomosugi N; Kawabata H; Ishikawa T; Nishikawa T; Yoshizaki K
Blood; 2010 Nov; 116(18):3627-34. PubMed ID: 20644113
[TBL] [Abstract][Full Text] [Related]
5. Inappropriate expression of hepcidin by liver congestion contributes to anemia and relative iron deficiency.
Suzuki T; Hanawa H; Jiao S; Ohno Y; Hayashi Y; Yoshida K; Kashimura T; Obata H; Minamino T
J Card Fail; 2014 Apr; 20(4):268-77. PubMed ID: 24440572
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid modulates iron metabolism imbalance in anemia of inflammation induced by LPS via reversely regulating hepcidin and ferroportin expression.
Han L; Liu Y; Lu M; Wang H; Tang F
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):280-285. PubMed ID: 30446224
[TBL] [Abstract][Full Text] [Related]
7. [Siwu decoction improves iron deficiency anemia in infant rats and regulates iron metabolism].
He R; Wang HJ; Zhou Y; Li JJ; Xu XY
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):944-950. PubMed ID: 28994539
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production.
Hashizume M; Uchiyama Y; Horai N; Tomosugi N; Mihara M
Rheumatol Int; 2010 May; 30(7):917-23. PubMed ID: 19639319
[TBL] [Abstract][Full Text] [Related]
9. IL-22 regulates iron availability in vivo through the induction of hepcidin.
Smith CL; Arvedson TL; Cooke KS; Dickmann LJ; Forte C; Li H; Merriam KL; Perry VK; Tran L; Rottman JB; Maxwell JR
J Immunol; 2013 Aug; 191(4):1845-55. PubMed ID: 23836059
[TBL] [Abstract][Full Text] [Related]
10. The tendency of anemia of inflammation in periodontal diseases.
Han Y; Luo Z; Yue ZG; Miao LL; Xv M; Chang S; Zhan Y; Hou J
Clin Sci (Lond); 2023 Feb; 137(3):251-264. PubMed ID: 36705427
[TBL] [Abstract][Full Text] [Related]
11. Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice.
Mihara M; Nishimoto N; Yoshizaki K; Suzuki T
Immunol Lett; 2002 Dec; 84(3):223-9. PubMed ID: 12413741
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
Shu T; Jing C; Lv Z; Xie Y; Xu J; Wu J
Eur J Haematol; 2015 Jan; 94(1):67-73. PubMed ID: 24954786
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid anemia.
Masson C
Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
[TBL] [Abstract][Full Text] [Related]
14. The effect of nonsurgical periodontal therapy on hepcidin and on inflammatory and iron marker levels.
Leite SAM; Casanovas RC; Rodrigues VP; Pereira AFV; Ferreira TCA; Nascimento FRFD; Nascimento JRD; Gomes-Filho IS; Bastos MG; Pereira ALA
Braz Oral Res; 2019 Sep; 33():e055. PubMed ID: 31531562
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.
Huang YH; Kuo HC; Huang FC; Yu HR; Hsieh KS; Yang YL; Sheen JM; Li SC; Kuo HC
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187366
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin is a key mediator of anemia of inflammation in Crohn's disease.
Basseri RJ; Nemeth E; Vassilaki ME; Basseri B; Enayati P; Shaye O; Bourikas LA; Ganz T; Papadakis KA
J Crohns Colitis; 2013 Sep; 7(8):e286-91. PubMed ID: 23219355
[TBL] [Abstract][Full Text] [Related]
17. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts.
Onuma E; Tsunenari T; Saito H; Sato K; Yamada-Okabe H; Ogata E
Int J Cancer; 2005 Sep; 116(3):471-8. PubMed ID: 15800941
[TBL] [Abstract][Full Text] [Related]
19. Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients.
Ibricevic-Balic L; Icindic-Nakas E; Hasic S; Kiseljakovic E; Sofo-Hafizovic A; Balic S
Med Arch; 2016 Dec; 70(6):429-432. PubMed ID: 28210014
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Lactoferrin Oral Administration in the Treatment of Anemia and Anemia of Inflammation in Pregnant and Non-pregnant Women: An Interventional Study.
Lepanto MS; Rosa L; Cutone A; Conte MP; Paesano R; Valenti P
Front Immunol; 2018; 9():2123. PubMed ID: 30298070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
